These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9691695)

  • 1. [Morphological signs of ineffective chemotherapy for experimental destructive pulmonary tuberculosis].
    Erokhin VV
    Probl Tuberk; 1998; (3):61-6. PubMed ID: 9691695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental inoculation of laboratory animals with samples collected from sarcoidal patients and molecular diagnostic evaluation of the results.
    Ikonomopoulos JA; Gorgoulis VG; Kastrinakis NG; Galanos AA; Karameris A; Kittas C
    In Vivo; 2000; 14(6):761-5. PubMed ID: 11204496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of cavitation in pulmonary tuberculosis.
    Helke KL; Mankowski JL; Manabe YC
    Tuberculosis (Edinb); 2006 Sep; 86(5):337-48. PubMed ID: 16359922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of the standard mode of chemotherapy for newly-diagnosed patients with destructive pulmonary tuberculosis with bacterial isolation].
    Mishin VIu; Chukanov VI; Vylegzhanin SV
    Probl Tuberk; 2001; (7):13-8. PubMed ID: 11763553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV
    Probl Tuberk Bolezn Legk; 2009; (4):23-7. PubMed ID: 19514450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cavern morphology and the dynamics of the bacterial population in different variants of an experimental model of cavernous pulmonary tuberculosis].
    Khomenko AG; Uvarova OA; Kozulitsyna TI; Golyshevskaia VI; Lesnaia AA
    Probl Tuberk; 1982 Jan; (1):53-8. PubMed ID: 7058193
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in the complex treatment of patients with acutely progressive pulmonary tuberculosis].
    Makieva VG; Polosukhin SM; Dryga OP; Mishin VIu
    Probl Tuberk; 2002; (12):26-9. PubMed ID: 12611331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrosternal lymphotropic chemotherapy and pneumoperitoneum in the treatment of drug-resistant destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV; Lobanovskiĭ VM
    Probl Tuberk Bolezn Legk; 2009; (5):21-6. PubMed ID: 19565808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the morphological diagnosis of drug-resistant pulmonary tuberculosis].
    Ziuzia IuR; Lepekha LN; Gedymin LE; Burtseva SA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (10):56-60. PubMed ID: 17139834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [To the problem of abacillary caverns in patients with pulmonary tuberculosis].
    Khudushina TA; Voloshina EP
    Probl Tuberk; 2003; (3):48-50. PubMed ID: 12744066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of M. tuberculosis Infection.
    Orme I; Gonzalez-Juarrero M
    Curr Protoc Microbiol; 2007 Nov; Chapter 10():Unit 10A.5. PubMed ID: 18770606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of sarcoidosis in a patient with persistent granular Mycobacteria followed up over 18 years].
    Ozerova LV; Shemetun ON
    Probl Tuberk; 2000; (2):51-2. PubMed ID: 10838915
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cellular composition of bronchopulmonary lavage fluid in pulmonary tuberculosis].
    Lobacheva OV; Evgushchenko GV
    Probl Tuberk; 1998; (3):32-6. PubMed ID: 9691686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental bioplasty of tuberculous caverns of the lung].
    Inchenko KS; Braude VI; Muldashev ER; Nigmatullin RT; Rymko LP
    Probl Tuberk; 1991; (8):72-4. PubMed ID: 1758865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathomorphological assessment of the therapeutic effect of mycobacteriophages in tuberculosis].
    Zemskova ZS; Dorozhkova IR
    Probl Tuberk; 1991; (11):63-6. PubMed ID: 1775467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudotumoral laryngeal tuberculosis].
    Zirlik S; Fuchs FF; Hahn EG; Zenk J; Wiest GH
    Med Klin (Munich); 2007 May; 102(5):393-5. PubMed ID: 17497091
    [No Abstract]   [Full Text] [Related]  

  • 20. [The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
    Erokhin VV
    Probl Tuberk; 2000; (5):15-9. PubMed ID: 11077845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.